Multiple Choice
What is the mechanism of action of the sipuleucel-T prostate cancer vaccine?
A) Dendritic cells are incubated with a fusion protein containing prostate specific antigen (PSA) and GM-CSF.
B) A plasmid that codes for an antibody that expresses prostate specific antigen (PSA) , and dendritic cells present PSA to T cells.
C) A single B cell clone that is tumor specific is grown in the lab and infused into the patient to produce large amounts of tumor specific antibody.
D) Patient tumor cells are exposed to a viral vector containing a gene for prostate specific antigen (PSA) , and then the tumor cells are infused into the patient to stimulate an immune response.
Correct Answer:
Verified
Correct Answer:
Verified
Q1: A defect in production of cryopyrin leads
Q2: Which is one disadvantage to cell-based anticancer
Q3: NY-ESO-1 would be a beneficial addition to
Q5: Which of the following is a marker
Q6: Which of the following is an outcome
Q7: Oprelvekin increases levels of:<br>A) Platelets<br>B) Neutrophils<br>C) Macrophages<br>D)
Q8: What is one role that type I
Q9: Which of the following may be administered
Q10: Recombinant IL-2 administration is appropriate for the